• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性翻修髋关节置换术:异位骨化一个此前未被认识到的危险因素。

Acute revision hip arthroplasty: a previously unrecognized risk factor for heterotopic ossification.

作者信息

Aljurayyan Abdulaziz, Tanzer Dylan, Tanzer Michael

机构信息

Division of Orthopaedic Surgery, McGill University Health Centre, 1650 Cedar Avenue, B5.159, Montreal, QC, H3G 1A4, Canada.

Sackler Medical School, Tel Aviv University, Tel Aviv, Isreal.

出版信息

Eur J Orthop Surg Traumatol. 2016 Feb;26(2):183-8. doi: 10.1007/s00590-015-1733-z. Epub 2016 Jan 2.

DOI:10.1007/s00590-015-1733-z
PMID:26724809
Abstract

BACKGROUND

The aim of this retrospective review was to determine the incidence and severity of heterotrophic ossification (HO) following acute revision total hip arthroplasty (THA), and whether this represents a significant risk factor for HO that should be treated prophylactically.

MATERIALS AND METHODS

A total of seven patients (three men and four women) with a mean age of 55 years (39-70 years) who underwent a reoperation of their THA for any reason that required a hip arthrotomy within 3 weeks of their primary or revision THA were included, with a mean follow-up of 8.8 years (2-12 years). All patients were evaluated radiographically for any evidence of HO and clinically using the Harris Hip Score.

RESULTS

All seven hips (100 %) developed HO, with 71 % being severe (Brooker III and IV HO). One hip (14 %) developed Brooker IV HO, four hips (57 %) developed Brooker III HO, and two hips (29 %) developed Brooker II HO. The patient's range of motion varied, but was very limited in three patients. Three patients (42.8 %) were not satisfied with their surgery; one patient had Brooker IV HO, and two patients had Brooker III HO.

CONCLUSION

Acute reoperation after primary or revision THA is a significant risk factor for the development of extensive HO, which requires prophylactic treatment.

摘要

背景

本回顾性研究旨在确定急性翻修全髋关节置换术(THA)后异位骨化(HO)的发生率和严重程度,以及这是否代表了一个应进行预防性治疗的HO的重要危险因素。

材料与方法

纳入7例患者(3例男性和4例女性),平均年龄55岁(39 - 70岁),这些患者因任何原因在初次或翻修THA后3周内进行了需要髋关节切开术的THA再次手术,平均随访8.8年(2 - 12年)。所有患者均进行了影像学检查以寻找HO的证据,并使用Harris髋关节评分进行临床评估。

结果

所有7个髋关节(100%)均发生HO,其中71%为重度(Brooker III级和IV级HO)。1个髋关节(14%)发生Brooker IV级HO,4个髋关节(57%)发生Brooker III级HO,2个髋关节(29%)发生Brooker II级HO。患者的活动范围各不相同,但3例患者的活动范围非常有限。3例患者(42.8%)对手术不满意;1例患者有Brooker IV级HO,2例患者有Brooker III级HO。

结论

初次或翻修THA后的急性再次手术是广泛HO发生的一个重要危险因素,需要进行预防性治疗。

相似文献

1
Acute revision hip arthroplasty: a previously unrecognized risk factor for heterotopic ossification.急性翻修髋关节置换术:异位骨化一个此前未被认识到的危险因素。
Eur J Orthop Surg Traumatol. 2016 Feb;26(2):183-8. doi: 10.1007/s00590-015-1733-z. Epub 2016 Jan 2.
2
The influence of heterotopic ossification on functional status of hip joint following total hip arthroplasty.异位骨化对全髋关节置换术后髋关节功能状态的影响。
Strahlenther Onkol. 2005 Aug;181(8):529-33. doi: 10.1007/s00066-005-1352-4.
3
Aspirin decreases heterotopic ossification after hip resurfacing.阿司匹林可降低髋关节表面置换术后异位骨化。
Clin Orthop Relat Res. 2011 Jun;469(6):1614-20. doi: 10.1007/s11999-011-1846-6.
4
Heterotopic ossification is less after THA in patients who receive aspirin compared to coumadin.与接受华法林治疗的患者相比,接受阿司匹林治疗的患者在全髋关节置换术后异位骨化较少。
Bull NYU Hosp Jt Dis. 2010;68(4):266-72.
5
Heterotopic ossification after total hip arthroplasty: our experience.全髋关节置换术后异位骨化:我们的经验
Musculoskelet Surg. 2011 Apr;95(1):1-5. doi: 10.1007/s12306-010-0091-6. Epub 2011 Jan 6.
6
[Prophylaxis of heterotopic ossification in hip revisions with 7 Gy single-dose radiation].[单次7 Gy放射预防髋关节翻修术中异位骨化]
Z Orthop Ihre Grenzgeb. 2002 May-Jun;140(3):317-22. doi: 10.1055/s-2002-32472.
7
Randomized trial comparing early postoperative irradiation vs. the use of nonsteroidal antiinflammatory drugs for prevention of heterotopic ossification following prosthetic total hip replacement.比较早期术后放疗与使用非甾体类抗炎药预防人工全髋关节置换术后异位骨化的随机试验。
Int J Radiat Oncol Biol Phys. 1997 Dec 1;39(5):961-6. doi: 10.1016/s0360-3016(97)00496-3.
8
The Impact of Heterotopic Ossification on Self-Reported Outcomes After Total Hip Arthroplasty Using the Direct Anterior Approach.直接前入路全髋关节置换术后异位骨化对患者报告结局的影响。
J Bone Joint Surg Am. 2020 Nov 4;102(Suppl 2):91-98. doi: 10.2106/JBJS.20.00071.
9
Incidence of Heterotopic Ossification Following a Multimodal Pain Protocol in Total Hip Arthroplasty With the Posterior Approach.后路全髋关节置换术中多模式镇痛方案后异位骨化的发生率
Orthopedics. 2018 Jan 1;41(1):e92-e97. doi: 10.3928/01477447-20171102-01. Epub 2017 Nov 9.
10
Size of ischial fibro-ostosis is associated with heterotopic ossification after total hip arthroplasty.坐骨纤维性骨化的大小与全髋关节置换术后异位骨化有关。
Int Orthop. 2019 Oct;43(10):2253-2259. doi: 10.1007/s00264-018-4234-y. Epub 2018 Dec 13.

引用本文的文献

1
Periprosthetic joint infection and heterotopic ossification after total hip arthroplasty: systematic review and meta-analysis.全髋关节置换术后假体周围关节感染与异位骨化:系统评价与荟萃分析
BMC Musculoskelet Disord. 2025 Aug 8;26(1):768. doi: 10.1186/s12891-025-09045-5.
2
Heterotopic hip ossification resection: monocentric experiences of associated factors, outcomes, and complications.异位性髋关节骨化切除术:相关因素、结果和并发症的单中心经验。
Int Orthop. 2024 Mar;48(3):699-704. doi: 10.1007/s00264-023-05993-6. Epub 2023 Sep 30.
3
Severe Heterotopic Ossification After Revision Total Knee Arthroplasty: A Case Report and Review of the Literature.

本文引用的文献

1
Do inflammatory markers portend heterotopic ossification and wound failure in combat wounds?炎症标志物是否预示着战伤中异位骨化和伤口愈合不良?
Clin Orthop Relat Res. 2014 Sep;472(9):2845-54. doi: 10.1007/s11999-014-3694-7. Epub 2014 May 31.
2
Celecoxib inhibits the heterotopic ossification in the rat model with Achilles tenotomy.塞来昔布抑制跟腱切断大鼠模型中的异位骨化。
Eur J Orthop Surg Traumatol. 2013 Feb;23(2):145-8. doi: 10.1007/s00590-012-0944-9. Epub 2012 Feb 10.
3
Preoperative comorbidity and modes of failure in revision hip arthroplasty: a single-surgeon series in a tertiary referral centre.
翻修全膝关节置换术后严重异位骨化:病例报告及文献复习。
J Am Acad Orthop Surg Glob Res Rev. 2022 Nov 11;6(11). doi: 10.5435/JAAOSGlobal-D-22-00053. eCollection 2022 Nov 1.
4
Preservation of the Acetabular Cup During Revision Total Hip Arthroplasty Using a Novel Mini-navigation Tool: A Case Report.使用新型微型导航工具在翻修全髋关节置换术中保留髋臼杯:一例报告
J Orthop Case Rep. 2018 Jan-Feb;8(1):53-56. doi: 10.13107/jocr.2250-0685.996.
5
The effect of late radiotherapy on the progression of heterotopic ossification following total hip arthroplasty.全髋关节置换术后晚期放疗对异位骨化进展的影响。
Eur J Orthop Surg Traumatol. 2018 Aug;28(6):1125-1131. doi: 10.1007/s00590-018-2185-z. Epub 2018 Mar 21.
6
Influence of surgical approach on heterotopic ossification after total hip arthroplasty - is minimal invasive better? A case control study.手术入路对全髋关节置换术后异位骨化的影响——微创入路是否更佳?一项病例对照研究。
BMC Musculoskelet Disord. 2017 Jan 21;18(1):27. doi: 10.1186/s12891-017-1391-x.
髋关节翻修术中的术前合并症与失败模式:三级转诊中心的单术者系列研究
Eur J Orthop Surg Traumatol. 2013 Apr;23(3):329-33. doi: 10.1007/s00590-012-0964-5. Epub 2012 Mar 16.
4
Heterotopic ossification following total hip replacement for acetabular fractures.髋关节置换术后髋臼骨折异位骨化。
Bone Joint J. 2013 Jan;95-B(1):95-100. doi: 10.1302/0301-620X.95B1.29721.
5
Prophylaxis of heterotopic ossification of the hip: systematic review and meta-analysis.髋关节异位骨化的预防:系统评价和荟萃分析。
Clin Orthop Relat Res. 2009 Dec;467(12):3283-9. doi: 10.1007/s11999-009-0924-5. Epub 2009 Jun 11.
6
Non-steroidal anti-inflammatory drugs after hip replacement.髋关节置换术后使用非甾体抗炎药。
BMJ. 2006 Sep 9;333(7567):507-8. doi: 10.1136/bmj.38960.600822.80.
7
Radiotherapy vs. nonsteroidal anti-inflammatory drugs for the prevention of heterotopic ossification after major hip procedures: a meta-analysis of randomized trials.放射治疗与非甾体抗炎药预防髋关节大手术后异位骨化的比较:一项随机试验的荟萃分析
Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):888-95. doi: 10.1016/j.ijrobp.2003.11.015.
8
Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty.用于预防髋关节置换术后异位骨化的非甾体类抗炎药。
Cochrane Database Syst Rev. 2004(3):CD001160. doi: 10.1002/14651858.CD001160.pub2.
9
Effects of heterotopic bone formation on outcome after hip arthroplasty.
ANZ J Surg. 2003 Jun;73(6):422-6. doi: 10.1046/j.1445-2197.2003.02647.x.
10
Incidence of heterotopic bone formation after major hip surgery.髋关节大手术后异位骨形成的发生率。
ANZ J Surg. 2002 Nov;72(11):808-21. doi: 10.1046/j.1445-2197.2002.02549.x.